Cambridge Investment Research Advisors, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 321 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$302
-1.6%
6,647
-11.1%
0.00%0.0%
Q2 2023$307
+1.3%
7,474
-11.8%
0.00%0.0%
Q1 2023$303
-16.1%
8,474
-11.3%
0.00%
-50.0%
Q4 2022$361
-99.9%
9,555
-12.5%
0.00%
-33.3%
Q3 2022$483,000
+17.2%
10,922
-1.8%
0.00%
+50.0%
Q2 2022$412,000
+6.2%
11,122
+6.3%
0.00%0.0%
Q1 2022$388,000
+22.0%
10,467
+0.2%
0.00%
+100.0%
Q4 2021$318,000
-43.8%
10,447
-38.1%
0.00%
-66.7%
Q3 2021$566,000
-26.4%
16,867
-12.5%
0.00%
-25.0%
Q2 2021$769,000
+14.9%
19,274
+29.6%
0.00%0.0%
Q1 2021$669,000
+193.4%
14,877
+294.3%
0.00%
+100.0%
Q4 2019$228,000
+9.6%
3,773
+8.8%
0.00%0.0%
Q3 2019$208,000
-6.7%
3,468
+0.1%
0.00%0.0%
Q2 2019$223,000
-21.8%
3,464
-1.3%
0.00%
-33.3%
Q1 2019$285,000
-8.7%
3,511
-41.9%
0.00%0.0%
Q3 2018$312,000
+47.2%
6,045
+18.6%
0.00%
+50.0%
Q2 2018$212,000
-14.2%
5,096
+4.5%
0.00%
-33.3%
Q3 2017$247,000
+11.3%
4,875
+11.8%
0.00%0.0%
Q2 2017$222,000
-17.5%
4,362
-22.3%
0.00%
-40.0%
Q4 2016$269,000
+17.5%
5,616
-10.1%
0.01%
+25.0%
Q3 2016$229,000
-9.1%
6,248
+0.4%
0.00%
-33.3%
Q1 2016$252,000
-41.3%
6,221
-10.3%
0.01%
-40.0%
Q4 2015$429,0006,9350.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
BB BIOTECH AG 6,529,838$404,393,00011.39%
DOWLING & YAHNKE LLC 676,379$41,888,0005.27%
Opus Point Partners Management, LLC 102,459$6,345,0004.19%
WILLIAM HARRIS INVESTORS INC 230,443$14,271,0003.43%
PINNACLE ASSOCIATES LTD 1,690,263$104,678,0002.20%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 21,298$1,319,0002.11%
Sonora Investment Management, LLC 126,763$7,850,0002.04%
Virtus ETF Advisers LLC 10,447$647,0001.78%
Apex Capital Management 1,020,096$63,175,0001.41%
PERKINS CAPITAL MANAGEMENT INC 19,900$1,232,0001.32%
View complete list of IONIS PHARMACEUTICALS INC shareholders